Healthcare provider profile · identity verified

Bryan Kent Stucky, MD

Family Practice · GARDEN CITY, KS · NPI 1518195213

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	532	139
Amlodipine Besylate	Amlodipine Besylate	495	120
Levothyroxine Sodium	Levothyroxine Sodium	492	114
Losartan Potassium	Losartan Potassium	416	111
Lisinopril	Lisinopril	220	57
Pantoprazole Sodium	Pantoprazole Sodium	204	45
Gabapentin	Gabapentin	202	34
Duloxetine Hcl	Duloxetine Hcl	199	42
Hydrochlorothiazide	Hydrochlorothiazide	192	49
Simvastatin	Simvastatin	169	38
Mounjaro	Tirzepatide	157	23
Warfarin Sodium	Warfarin Sodium	156	suppressed
Pravastatin Sodium	Pravastatin Sodium	147	32
Tamsulosin Hcl	Tamsulosin Hcl	147	35
Metformin Hcl	Metformin Hcl	145	38
Zolpidem Tartrate	Zolpidem Tartrate	140	26
Metoprolol Tartrate	Metoprolol Tartrate	124	25
Montelukast Sodium	Montelukast Sodium	124	29
Potassium Chloride	Potassium Chloride	121	30
Furosemide	Furosemide	119	30
Metoprolol Succinate	Metoprolol Succinate	116	31
Meloxicam	Meloxicam	108	27
Rosuvastatin Calcium	Rosuvastatin Calcium	105	31
Eliquis	Apixaban	91	14
Sertraline Hcl	Sertraline Hcl	91	24
Citalopram Hbr	Citalopram Hydrobromide	90	22
Trazodone Hcl	Trazodone Hcl	89	16
Ozempic	Semaglutide	88	18
Jardiance	Empagliflozin	87	15
Omeprazole	Omeprazole	84	18
Allopurinol	Allopurinol	79	17
Metformin Hcl Er	Metformin Hcl	73	21
Alprazolam	Alprazolam	70	12
Lovastatin	Lovastatin	70	19
Fluoxetine Hcl	Fluoxetine Hcl	66	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	63	13
Fluticasone Propionate	Fluticasone Propionate	59	15
Donepezil Hcl	Donepezil Hcl	55	13
Spironolactone	Spironolactone	55	16
Amitriptyline Hcl	Amitriptyline Hcl	53	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	53	11
Paroxetine Hcl	Paroxetine Hcl	51	suppressed
Synthroid	Levothyroxine Sodium	51	suppressed
Tramadol Hcl	Tramadol Hcl	47	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	46	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	12
Olmesartan Medoxomil	Olmesartan Medoxomil	45	12
Estradiol	Estradiol	44	suppressed
Xarelto	Rivaroxaban	44	suppressed
Clopidogrel	Clopidogrel Bisulfate	43	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	43	13
Breo Ellipta	Fluticasone/Vilanterol	42	suppressed
Cephalexin	Cephalexin	42	19
Myrbetriq	Mirabegron	42	suppressed
Oxycodone Hcl	Oxycodone Hcl	42	11
Carvedilol	Carvedilol	40	suppressed
Glipizide Er	Glipizide	39	suppressed
Finasteride	Finasteride	38	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	38	11
Pregabalin	Pregabalin	35	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Atenolol	Atenolol	33	suppressed
Januvia	Sitagliptin Phosphate	33	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	33	suppressed
Spiriva Respimat	Tiotropium Bromide	33	suppressed
Ipratropium Bromide	Ipratropium Bromide	32	14
Glipizide	Glipizide	31	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	13
Bumetanide	Bumetanide	30	suppressed
Fentanyl	Fentanyl	30	suppressed
Mirtazapine	Mirtazapine	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Celecoxib	Celecoxib	28	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	28	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Rybelsus	Semaglutide	27	suppressed
Trulicity	Dulaglutide	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Digoxin	Digoxin	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	16
Mupirocin	Mupirocin	24	suppressed
Famotidine	Famotidine	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	22	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	21	suppressed
Nystatin	Nystatin	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	20	suppressed
Primidone	Primidone	20	suppressed
Baclofen	Baclofen	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Estradiol (Once Weekly)	Estradiol	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Vascepa	Icosapent Ethyl	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Prednisone	Prednisone	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Dutasteride	Dutasteride	15	suppressed
Invokana	Canagliflozin	15	suppressed
Premarin	Estrogens, Conjugated	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Linzess	Linaclotide	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	11
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Temazepam	Temazepam	12	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Niacin Er	Niacin	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error